Bridging living cortical networks with digital infrastructure. Featuring our proprietary 4-core quorum-voting architecture, monolithic 3D-printed microfluidics, and automated closed-loop micro-life support.
As modern artificial intelligence scales, conventional von Neumann semiconductor architectures face irreversible thermodynamic and algorithmic walls.
Frontier model training and inference demand gigawatt-scale grid allocations and millions of gallons of cooling water. Scaling silicon cannot sustain global computational demand.
The physical separation of arithmetic logic units (ALUs) and memory buses (HBM/SRAM) produces massive latency penalties and dissipates over 80% of silicon power in transit.
Silicon neural networks rely on static weights trained over millions of backpropagation iterations. They cannot adapt continuously in real time to non-stationary environments without retraining.
Biological neural networks do not compete on raw clock rate—they redefine computational physics through native plasticity and extreme thermodynamic efficiency.
| Performance Dimension | Silicon (CPUs / GPUs / NPUs) | BioLeela Wetware Compute Core |
|---|---|---|
| Energy per Synaptic Operation | 10-9 to 10-11 Joules (High power draw) | 10-15 to 10-16 Joules (10,000x Lower) |
| Compute & Memory Architecture | Separated (Bus latency & heating) | Monolithic: Co-located at physical synapse |
| Learning Mechanism | Simulated backpropagation via gradient descent | Spike-Timing-Dependent Plasticity (STDP) |
| Adaptability | Requires full offline model retraining | Continuous few-shot online self-organization |
| Noise Handling | Degrades digital logic; requires high precision | Exploits thermal noise for stochastic inference |
Solving biological stochasticity and culture senescence through multi-core redundancy and automated micro-life support.
Individual biological neural cultures exhibit natural firing stochasticity and senescence. BioLeela splits synchronized sensory input across four independent 256-channel MEA cultures.
A precision 3D-printed biocompatible resin manifold ("Mother-Block") houses all fluidic and gas routing internally, completely eliminating external tubing and leak paths.
Custom linear screw-in cartridge diaphragm valves engineered for sub-micron metering and zero-power latching hold.
Thermal stability is paramount for electrophysiological consistency. BioLeela integrates a Phase Change Material (PCM) thermal reservoir.
Tracing the complete pneumatic chain from 900 psig disposable CO₂ cylinder down to sub-micron cell culture headspace perfusion.
Standard 3/8"-24 threaded CO₂ cylinder (900 psig) connects to Beswick GCP-F40-6-1438-3VK pierce fitting with 40µm filter. Regulated by Beswick PRD4HP 3-stage regulator (3,000 psi in → 2.5 psig out).
10-32 Manifold Cross equipped with Beswick RVD-1N1 relief valve (set to 6.0 psig overpressure shunt) and Honeywell MPR digital piezoresistive pressure sensor (0–6 psig I2C) for cylinder exhaustion alerts.
Custom 10BY cartridge valve with series 50µm micro-orifice meters gentle 0.4 mL CO₂ doses into the AirHub blending cavity, completely eliminating gas overshoot.
GSS ExplorIR-M-20 NDIR CO₂ sensor (0–20% range) and SST Sensing LuminOx LOX-02-F optical O₂ sensor sit in the dry pre-humidifier stream, protecting optics from condensation.
Heated pass-over wetted wick chamber (37.0°C) introduces pure molecular water vapor (>90% RH with zero droplets). Saturated air is routed via a trace-heated runner (37.5°C) to prevent line condensation.
Symmetric H-tree splitter routes gas through 4x sterile 0.22µm hydrophobic PTFE filters into culture headspaces (Z=14.0mm). Direct return header collects gas into a moisture trap and Bartels mp6 recirculation pump.
In single-pass exhaust, a 16g CO₂ cylinder empties in 10 days while drying out culture media. In BioLeela's active closed loop, saturated 37°C gas recirculates continuously at 12–16 mL/min. CO₂ is only injected to replace cellular respiration, allowing a single 16g cylinder to last over 6 months with zero media evaporation.
A disciplined 3-phase go-to-market model capturing immediate high-margin revenue before scaling to hybrid edge processors ($120B+ Combined TAM).
Serving pharmaceutical companies and CROs by screening drug candidates directly on functional, learning biological neural networks.
Deploying specialized hybrid bio-processors for continuous analog anomaly detection and adaptive robotics.
Integrating 3D vascularized organoid arrays into non-von Neumann computing clusters alongside silicon GPUs.
Standardized physical, mechanical, pneumatic, and biological operating parameters.
Whether you are a pharmaceutical researcher seeking pilot drug-screening validation, a robotics team interested in adaptive reservoir computing, or a deep-tech investor, we welcome conversations.